![Rodney Young](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Rodney K.
B. Young worked as Chief Financial Officer at Extropy Pharmaceuticals, Inc. from 2003 to 2005.
From 2005 to 2013, served as Chief Financial Officer, VP & Head-IR at StemCells, Inc. Held the position of Chief Financial Officer at Aimmune Therapeutics, Inc. from 2014 to 2015.
Worked as Chief Financial Officer at Cellerant Therapeutics, Inc. from 2015 to 2019.
Served as Chief Financial Officer & Secretary at Rapt Therapeutics, Inc. from 2019 to 2026.
Completed undergraduate studies at The University of Chicago.
Earned an MBA from The University of Chicago Booth School of Business.
Eerdere bekende functies van Rodney Young
| Bedrijven | Functie | Einde |
|---|---|---|
| RAPT THERAPEUTICS, INC. | Financieel Directeur/CFO | 03-03-2026 |
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer | Financieel Directeur/CFO | 01-11-2019 |
| AIMMUNE THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-02-2015 |
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology Researches and develops stem cell therapeutics | Financieel Directeur/CFO | 01-12-2013 |
Extropy Pharmaceuticals, Inc. | Financieel Directeur/CFO | 01-01-2005 |
Opleiding van Rodney Young
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology Researches and develops stem cell therapeutics | Health Technology |
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer | Health Technology |
Extropy Pharmaceuticals, Inc. | |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Rapt Therapeutics, Inc.
 Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
